Literature DB >> 22118409

Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.

Carolin Daniel1, Harald von Boehmer.   

Abstract

Fopx3(+) expressing regulatory T cells (Tregs) function as an indispensable cellular constituent of the immune system by establishing and maintaining immunological self-tolerance. T cell receptor (TCR) ligands of high agonist activity, when applied in vivo under subimmunogenic conditions, convert naive but not activated T cells into stable Tregs expressing Foxp3. Tolerogenic vaccination with strong-agonist mimetopes of self-antigens may function as a safe and highly specific instrument in the prevention of autoimmune disease by promoting self-antigen-specific tolerance. In this review, we address the requirements for generation of dominant tolerance exerted by Foxp3(+) Tregs in autoimmune disease with special focus on type 1 diabetes (T1D). Further understanding of differentiation of T cells into Tregs at the cellular and molecular level will facilitate development of additional tolerogenic vaccination strategies that can be used in prevention as well as therapeutically to combat unwanted immunity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118409     DOI: 10.1016/B978-0-12-387827-4.00005-X

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  11 in total

1.  A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function.

Authors:  Stefanie Kälin; Maike Becker; Verena B Ott; Isabelle Serr; Fabian Hosp; Mohammad M H Mollah; Susanne Keipert; Daniel Lamp; Francoise Rohner-Jeanrenaud; Victoria K Flynn; Martin G Scherm; Lucas F R Nascimento; Katharina Gerlach; Vanessa Popp; Sarah Dietzen; Tobias Bopp; Purna Krishnamurthy; Mark H Kaplan; Manuel Serrano; Stephen C Woods; Philipp Tripal; Ralf Palmisano; Martin Jastroch; Matthias Blüher; Christian Wolfrum; Benno Weigmann; Anette-Gabriele Ziegler; Matthias Mann; Matthias H Tschöp; Carolin Daniel
Journal:  Cell Metab       Date:  2017-09-05       Impact factor: 27.287

2.  Local "on-demand" generation and function of antigen-specific Foxp3+ regulatory T cells.

Authors:  Scott W McPherson; Neal D Heuss; Dale S Gregerson
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

Review 3.  Immunotherapy in autoimmune type 1 diabetes.

Authors:  Benno Weigmann; Randi K Franke; Carolin Daniel
Journal:  Rev Diabet Stud       Date:  2012-11-15

4.  Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort.

Authors:  António Marinho; Cláudia Carvalho; Daniela Boleixa; Andreia Bettencourt; Bárbara Leal; Judite Guimarães; Esmeralda Neves; José Carlos Oliveira; Isabel Almeida; Fátima Farinha; Paulo P Costa; Carlos Vasconcelos; Berta M Silva
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B.

Authors:  Z-J Pan; C G Horton; C Lawrence; A D Farris
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

Review 6.  Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.

Authors:  Shifra Ash; Shai Yarkoni; Nadir Askenasy
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

7.  Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming.

Authors:  Navin R Mahadevan; Veronika Anufreichik; Jeffrey J Rodvold; Kevin T Chiu; Homero Sepulveda; Maurizio Zanetti
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

Review 8.  Antigen-specific therapeutic approaches for autoimmunity.

Authors:  Pau Serra; Pere Santamaria
Journal:  Nat Biotechnol       Date:  2019-02-25       Impact factor: 68.164

9.  Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.

Authors:  Johannes M van Noort; Malika Bsibsi; Peter J Nacken; Richard Verbeek; Edna H G Venneker
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

10.  Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells.

Authors:  Scott W McPherson; Neal D Heuss; Mark J Pierson; Dale S Gregerson
Journal:  J Neuroinflammation       Date:  2014-12-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.